%20(3).png)
From this year’s IMCAS Congress in Paris, we brought back one of the most exciting innovations in aesthetic medicine – the advanced peeling systems by Supernova Laboratories. This new generation of biphasic peels combines the power of acids with oxygenating technology to deliver visible results without invasive procedures, needles, or extended downtime.
The Nebula ACTO2 and Nebula ACTO2 Orion treatments introduce a patented technology for biorevitalization and biostimulation suitable for all skin types, including sensitive skin. Thanks to a unique combination of TCA, mandelic acid, azelaic acid derivative, and an oxygenating phase enriched with perfluorocarbons, the treatment supports intensive cellular renewal, collagen stimulation, and overall skin brightening.
The ACTO2 technology uses an oxygenating effect that supports cellular metabolism, tissue regeneration, and collagen production while helping to reduce inflammation and improve skin tolerance, even for sensitive skin types.
%20(2).png)
In a very short time, Supernova Laboratories has expanded into 13 countries and become a key player in the European market of non-invasive chemical peels. The products have been showcased at the world’s leading aesthetic medicine congresses, including IMCAS Paris, AMWC Monaco, and Dubai Derma.
We believe SUPERNOVA will bring a new dimension of professional skincare to both clients and aesthetic professionals – effective, gentle, and technologically advanced.
